SOMMY Sumitomo Chemical Co., Ltd.

OTC
$15.16

Sumitomo Chemical Co., Ltd. Q2 F2027 Earnings Call Transcript

AI Conference Call Analysis

Sign in or subscribe to read.
Matsuo
General Manager, Accounting Department
It is now the scheduled time to start, so we would like to start the conference call regarding the financial results for fiscal year 2026, second quarter. Thank you for your participation. Today, Yamauchi, Managing Executive Officer, will explain the financial results for fiscal year 2026, second quarter. Later on, joined by Mr. Matsuo, General Manager, Accounting Department, will open the floor to Q&A later. We schedule to end at 4.50 p.m. Without further ado, Mr. Yamauchi, please go ahead.
Yamauchi
Managing Executive Officer
Good afternoon. I'm Yamauchi from Sumitomo Chemical. Thank you very much for attending our conference call despite your busy schedule. I'd like to thank investors and analysts for your daily understanding and support to our management. Thank you very much for that. Now let me start with the briefing of financial results for fiscal year 2026 second quarter. Please look at slide page 4. Before explaining the details of financial results, I would like to give a brief update on the status of profit and loss of the second quarter. Core operating income was 144.5 billion yen. Net income attributable to owners of a parent was 82.9 billion yen, both increasing significantly compared to the same period of the previous year and exceeded the forecast announced in August. The first half results were its second highest first half results on record. Regarding the primary factors behind the year-on-year increase in cooperating income, first ICT and mobility solutions, although shipments of display-related materials decreased with semiconductor shortages, shipments of semiconductor processing materials increased. Agro and Life Solutions Business conditions for crop protection products outside Japan have been slow to recover. Shipments of crop protection products in Japan have remained steady and profit margins for feed additives improved. Essential green materials Petro-Arabic's financial results improved due to the situation in the Middle East, while temporary inventory valuation gains also significantly boosted core operating income. Performance is solid. and with Sumitomo Pharma's capital increase, the E ratio improved significantly to 0.73 times. Consolidated financial results of the second quarter for FI2026, sales revenue was ¥1,172.8 billion, up ¥77.4 billion year-on-year. Core operating income expressing recurring earnings power was 144.5 billion yen up 35.8 billion yen year on year. Non-recurring items not included in core operating income was a loss in total of 6.5 billion yen, worsening by 1.4 billion yen compared to the previous year. As a result, operating income was a profit of 138.1 billion yen up 34.4 billion yen year-on-year. Finance income was a loss of 16.1 billion yen, worsening of 300 million yen year-on-year. Gain or loss on foreign currency transactions included the finance income or expenses was a loss of 9.4 billion yen, worsening of 3 billion yen year on year. Income tax expenses was 16.3 billion yen compared to the same period of a previous year when tax burden was reduced due to the write-off deferred tax liabilities tax burden increased by 19.3 billion yen. Net income loss attributable to non-consolidated interests was a loss of ¥22.8 billion. As a result, net income attributable to owners of a parent for the second quarter was a profit of ¥82.9 billion, improvement of ¥43.2 billion year-on-year. Exchange rate announced a price which impacted our performance. The average dollar rate during the term was 159.49 yen to a dollar and NAFSA price was 107,500 yen per kiloliter. Yen weakened and feedstock price increased year on year. Next, sales revenue by reporting segment. Please move to page 6. Total sales revenue was up 77.4 billion yen year on year. By segment, sales revenue increased in all segments except essential and green materials where reseal of petro-arabic products concluded. As for year on year changes of sales revenue by factor, Sales price increased by 84 billion yen. Volume decreased by 64.7 billion yen. Foreign exchange transaction variance of foreign subsidiary sales revenue increased by 58.1 billion yen. Next is page 7. Total core operating income increased by 35.8 billion yen year-on-year. Analyzing by factor, price was plus 17.5 billion yen, cost minus 4.5 billion yen. Volume variance including changes in equity earnings of affiliates was plus 22.8 billion yen. Next, performance by segment. Please move to page 8. Agro and Life Solutions Segment Core operating income was a profit of ¥20.8 billion up ¥9.6 billion year-on-year. Income of crop protection products dropped slightly because of slow recovery in business environment outside of Japan. Regarding the feed additives, while rising market prices have led customers to become more cautious in their purchasing decisions, the same market upturn has improved our profit margins, resulting in an increase in income. Next page. ICT and mobility solution segment. Co-operative income was a profit of 31.9 billion yen, down 1.2 billion yen year-on-year. For display-related products, absence of prior year gain on the sale of a large LCD polarizing film business, decline in mobile-related shipments due to shortage of semiconductors, and decline in the selling prices of polarizing films led to decline in income. in semiconductors-related products. Though there was increase in fixed costs due to capacity expansion, shipments and profit increased due to growing demand for semiconductors. For mobility-related products, increase in shipments of super-engineering plastics led to increasing income. Next page. Advanced medical solution segment. Core operating income was a loss of 3.7 billion yen. Down 2.3 billion yen year on year. Income dropped as a result of difference in sales mix of active pharmaceutical ingredients and intermediates and decline in profit margin at affiliated company due to situation Middle East. Next page. Extension green material segment. Co-operating income was a profit of 62.1 billion yen, increase of 80.7 billion yen year on year. Income increased as a result of inventory valuation gains in Japan and Singapore, accompanying increased feedstock and product market prices. Further, at Petro-Arabic Saudi Arabia, impact of prior year periodic plant maintenance and improvement of refining margins improved for equity method investment profit leading to improved income. Next page.
Matsuo
General Manager, Accounting Department
In Tsumitomo Pharma segment, core operating income was 43.6 billion yen down 53.8 billion yen year on year. Shipments increased thanks to growth in sales of Orgovix, a therapeutic agent for advanced prostate cancer, and Gemtisa, a treatment for overactive bladder. On the other hand, there was an absence of the gain on the sale of the Asian business in the prior year, as well as the impact of lower shipments resulting from that sale. This concludes the overview of results by segment. On the next slide, I will explain the consolidated statement of financial position. Total assets as of the end of September 2026 was 3,626.1 billion yen, an increase of 221 billion yen from the end of the previous fiscal year. The main factors were a temporary increase in working capital such as trade receivables and inventories in current assets owing to the restart of the Chiba plant following the schedule maintenance carried out in January through March 2026 and the surge in NAFSA prices. and an increase in investment securities in non-current assets. Interest-bearing liabilities were ¥1,087.4 billion, a decrease of ¥64.1 billion from the end of the previous fiscal year. Equity was ¥1,482.6 billion, an increase of ¥246 billion from the end of the previous fiscal year. This was mainly due to net income attributable to owners of the parent and Sumitomo Farmer's capital increase through a public offering. As a result of this, equity ratio and DE ratio significantly improved to 32.1% and 0.73 times respectively. Next, I will explain about the consolidated statement of cash flows. Please look at page 14. Cash flows from operating activities were an inflow of 66.6 billion yen, an increase of 8.9 billion yen year on year. The increase was due mainly to improved profit. Thank you very much. and others. As a result, free cash flows were an outflow of 18.3 billion yen, a deterioration of 59.3 billion yen compared with an inflow of 41 billion yen in the same period of the prior year. Cash flows from financing activities were an inflow of 16 billion yen due mainly to Sumitomo Farmer's capital increase of the Republic offering, an increase of inflow of 130.8 billion yen year on year. Next, I will explain our financial forecast for FY2026. Please turn to slide 16. Let me begin with the business environment surrounding the company. As for economic conditions, although growth in the field of technology is firmly supporting the global economy, the outlook remains uncertain due to geopolitical risks, including tensions in the Middle East. In the business environment section, we show our main business areas and our assessment of their business environment using weather icons. Starting from the top, for crop protection, the recovery of crop protection products outside Japan has been delayed. For feed additives, the temporary supply shortage caused by the Middle East situation has been resolved and the current supply-demand balance has been settling down. Although profit margin improved in the first half, the outlook for the second half and beyond remains uncertain. For displays, the mobile device market has become sluggish due to worsening procurement conditions for memory chips and other components. Silicon semiconductors remain solid, mainly driven by AI-related areas. For petrochemicals and raw materials, we have secured enough raw materials to meet current production plans, but the impact of high raw material prices continues. This concludes the business environment. I will now give an overview of our financial forecast. Please turn to slide 17. This is a summary of our financial forecast for FY26. We have revised the previous forecast announced in May to reflect recent business trends. Core operating income for FY26 is projected to be 270 billion yen, an upward revision of 55 billion yen from the previous forecast of 250 billion yen. As a result, core operating income is expected to reach a new record high. By a segment, Core Income and ICT Mobility Solutions, Essential and Green Materials, and Semitomo Farmer 3 segments were revised upwards. The details will be explained in later slides. The net income attributable owners of the paradigm projected to be 90 billion yen upward revision of 20 billion yen from the previous forecast of 70 billion yen. The year-end dividend is revised upward to 9 yen with a 1 yen increase. As a result, annual dividend is projected to be 17 yen, 1 yen higher than last projected. Please go to page 18. For FY2026, we forecast the following. Sales revenue is 2 trillion 490 billion yen, up 130 billion yen from the previous forecast. Core operating income of 270 billion yen, as mentioned in the previous slide. Net income attributable to owners of the parent being 90 billion yen. For our exchange rate and NASA price assumptions, we assume an exchange rate of 150 yen to the dollar for the second half or 157 yen for the full year and 99,000 yen per kiloliter for the full year. Next, I'll explain slide 19, sales, revenue, and core operating income by reporting segment. Looking at the full year forecast by segment for agro and life solutions, although a profit margin Formethionine has improved the recovering sales of crop protection products outside Japan has been delayed, so we have left the previous forecast unchanged. For ICT and mobility solutions, we expect an increase from 55 billion to 60 billion due to increased shipments of semiconductor processing materials. For essential and green materials, we expect a large increase in profit from ¥20 billion to ¥75 billion due to the improvement in petrol rock big profit and loss that has been impacted by the Middle East situation and temporary inventory valuation gains. For Sumitomo Farmer, we expect an increase in profit from ¥94 billion to ¥108 billion due to strong sales of Gem Tessa. Please note that the lower profit in the others segment compared with the previous forecast is because we have factored in certain levels of risks. This concludes our explanation of the financial results and forecasts. We will now like to open to the floor and receive your questions.
Yamauchi
Managing Executive Officer
Thank you very much. Now we would like to receive your questions. Now we will have the first question. For Morgan Stanley, MUFG Securities, Mr. Watabe. Thank you for your presentation. My name is Watabe. About agro and life, I had a question. First, in the second quarter, Compared to the forecast, it is lower, so what is the background for that? And the second half, there's upward revision. Overseas, crop protection chemicals were slow in recovering, but what's the background? And what's the situation by region about agro? And methionine market price seems to be fluctuating, so could you also explain that? Yes, thank you for your question. Overseas crop protection chemicals. Demand recovery is the lead in Middle and South America. Previous year, compared to 2005, 2026, we accept a recovery in Latin America and we expected recovery of a market, but there's a delay in recovery. One factor is the credit uncertainties in the farmers, which has not yet been resolved. And this year, Super El Nino is being mentioned. So this impact seems to be seen somewhat in Brazil. It's not yet a level that would affect the cultivation, but the farmers are refraining from purchasing, so there is a delay in recovery of demand. And by region, North America, It's not that it is worsening, but there is a shift of shipments from the first half to the second half. And in India, in the first quarter, because of El Niño, monsoon arrival is delayed, but finally it is starting to rain. But the volume of rain seems to be low. So compared to the forecast, there is an underachievement. And in India, second half, Indifreen was launched last year, so we hope we can recover through these products in the second half. And methionine, in the first half, there were some confusions, and the market price remained high. It is stabilizing slightly now. And for the second half, the assumption is that if a level, the sales price in the forecast is expected. So underachievement in the first half is the delay in the middle, in the Central and South America and impact of monsoon in India. which led to underachievement and it seems that there is an increase in the second half because there is a shift and the additional messianic is expected to be better than the original forecast. For the forecast in May, we didn't expect any positive figures from methionine, but in the current forecast, we made an upward revision of income. But in general, for the crop protection chemicals compared to May, we have incorporated some downward revision. I think you mentioned that you expected overachievement in the second half, but yes, your explanation was clear. Thank you.
Matsuo
General Manager, Accounting Department
Thank you very much, Mr. Watabe. I would like to take the next question from Mizuho Securities. Mr. Yamada, please go ahead. This is Yamada from Mizuho Securities speaking. Thank you. I have one question regarding ICT and mobility solutions. The display, the information, Appliance is not doing well and usually in this section there is a revision but the first half of $13.9 billion and the second half revised is $28.1 billion core operating income. So it seems that there's no difference between the first and second half. Is that because, or correct to think that that is because the semiconductor is going to grow in the second half? And if it is a semiconductor, what is strongly performing within that? And regarding the resist sales situation, are there any changes to the new product sales? Can you share that with us? Thank you very much for your question. FY26, the difference between the first and second half is your question is how I understood it. Well, first of all, regarding the display, As usually is, there is a difference between the first and second half. Compared to the first half, the second half, due to the seasonality, there is a decline in profit. That is our projection. As for the semiconductors, compared to the first half, The second half is going to further grow. That is our outlook. Therefore here, the usually occurring difference between the first and second half is becoming slightly milder. Is there a certain product that is contributing to this? Semiconductor related product markets is strongly performing. So in our case, at this point, is the front end resist and semiconductor chemicals for us. And these products are performing well for us. Super engineering plastics was performing well as well. How much of a positive impact do they have for the volume increase? And is this situation going to continue in the second half? For the silver engineering plastics, I did explain in the first quarter, the Chinese economic stimulus measures due to that towards the electronic components, the shipment is strong. And that market price is continuing. Okay, understood. Thank you very much. I have high expectations. Thank you.
Yamauchi
Managing Executive Officer
Thank you very much, Mr. Yamada. The next question from SMBC Nuclear Securities, Mr. Miyamoto. Thank you. I'm Miyamoto from SMBC Nuclear Securities. I have a question about essential green materials. First, Compared to the previous forecast, the first half, it is quite upward by about 20 billion. And towards the second half, it is about 13 billion. Petro-Arabic net loss. The level in July-September was very high, as high as the previous quarter. I don't expect such a large loss, but out of assumptions for those figures, NAFSA shortage in Singapore is having an impact. So could you tell me the factor for your forecast for essential and green materials? Comparison with the first half, for essential and green materials, what was good about the first half? The forecast in August, compared to the forecast in August, as of August, in the first half, inventory evaluation gains was posted, and about half, we thought, with the civilization situation in the Middle East, The second half will start with losses. That was our forecast. But NAFSA remains at a high price. So the violation loss of the first quarter still remains. Another point. In the forecast of August, some Under other items, we expected some gains from sales of businesses, but actually in the first half, some was reflected in essentials. That was the situation in the first half. So throughout the year, second half looks weaker. First for petro-rabic results up to September is already announced. and in our case, the third quarter includes those assumptions. But from October to December, the refining margin at the moment is advancing quite steadily, but there are also risk factors. So for the fourth quarter, We are not assuming positive factors. And NAFSA price currently is more than 100,000 yen. But towards the end of the year, we expect 90,000 yen in the second half. So for the inventory valuation loss or gains, we expect there will be some recovery in the second half. And what is the situation in Singapore? In Singapore, there is not much change. After the Fourth Majeure Declaration, it is still not being lifted. NAFSA price remains at a high level, and NAFSA is becoming easier to procure, but We have to consult with the customers in conducting these operations. So the level of the operation remains at a similar level as that of the first quarter. Thank you very much. And for NASA price, the assumption three months ago was 104,000. The result was 107,000. It's not that different. But Singapore operations in Singapore, the spot price for NAFSA and crude oil would directly impact. So maybe that was the factor of the impact. And for the gains of selling the business, is that at the two-digit level? Yes, first for NAFSA, in the second quarter we expected higher levels, but the inventory valuation loss is the price at the end of the term. So we assumed some drop at the end of the second quarter, and the sales gains We cannot, there's nothing that we can talk too much. We expect about 5 billion yen, but it is more than that. Under summary, the figures excluding those gains are included. So if you calculate from that, I think you can have an idea of the amount. Yes, I understand. Thank you very much.
Matsuo
General Manager, Accounting Department
Mr. Miyamoto, thank you very much. I would like to take the next question from Daiwa Securities. Mr. Umebayashi, please go ahead. Thank you. This is Umebayashi from Daiwa Securities. My question may be slightly in detail. The core operating income, the other adjusted areas, the second half was about minus 30 billion. And in your previous explanation, you said that you are reflecting some risks to a certain level. So is it okay to simply look at it as a buffer, or is there some specific item for this, is what I would like to know. And similar to that, the core operating income and operating income, and between that, the first half was minus 6.5. and the second half is about 49 billion after all the calculations. So the reason why this negative number is going to become enlarged in the second half is I would like to know the reason. Thank you very much for your question. For the other risk factors, money amount wise, it's about 10 billion yen that is incorporated. At the start of the fiscal year, or the quarter, which is May, we did reflect the risks of the Middle East situation, and as a result, a similar amount is incorporated. It's not that specific risks are existing. The Middle East situation is still uncertain, so we have reflected that. And also, The inventory valuation, a positive number. The NAFSA, we're looking at 90,000, and we assume that the valuation is going to remain to the second half, but there are areas that are difficult to have a clear visibility. So including those type of risks as well, we are incorporating it as risk factors. Thank you very much. The non-recurring items. Well for non-recurring items, the business situation is still uncertain. So last fiscal year, There was about nine non-recurring items, about 55 billion yen, that was actually reflecting such as the business structuring, restructuring expenses and others. So we are at the... At this point, incorporating some risk factors. So same as the last fiscal year, towards the second half, it becomes more prominent. So that is why we're reflecting these within the second half numbers as well. Thank you very much. Related to Singapore, is there a possibility that something may come up? Apologies, I cannot speak about the content of this, so I would like to refrain from commenting. Okay, understood. That is all. Thank you. Thank you.
Yamauchi
Managing Executive Officer
Thank you very much, Mr. Umabayashi. The next question is from BOA Securities, Mr. Enomoto. Thank you. My name is Enomoto from BOA. From about ICT and mobility, photo resist or semiconductor chemicals, semiconductor materials, what is the situation with price revision? The competitors are talking about revising the price and the things that would affect your company as well. Yes, thank you for the question. Well, mainly with a higher feedstock prices, you're asking about price revision in a certain company. Yes, in our case also we are consulting with our customers and revise to an appropriate price level. If possible, could you tell me what would be the scale? And with higher feedstock prices, there is price revision, but what is the assumption for the spread? I think the strong demand, you can enjoy some spread. The scale of the amount, I have to refrain from mentioning that, and improvement of spread, Also, that is our sales strategy, so it's quite difficult to talk about it, but in terms of cost, not only feedstock price, but fixed cost is also increasing, including labor cost. So, including that, we are having discussions about price revision. Understand. Thank you very much. Thank you.
Matsuo
General Manager, Accounting Department
Mr. Inamoto, thank you very much. We would like to take the next question from Nomura Securities. Mr. Okazaki, please go ahead. This is Okazaki from Nomura Securities. Thank you very much. Against the first half, the second half, you have announced an increase in dividend. I would like to know the way of thinking behind this. You're aiming for a 24 yen per share dividend. I know that. But this time, Sumitomo Pharma or ICT performs strongly. But on the other hand, maybe it's temporarily, but raw big or methionine market price is improving. And that is contributing to the improvement of profit. But moving forward, you would like to avoid from decreasing the dividend. But what is the direction? And I would like to know the thoughts behind dividends. That is all. Thank you very much for your question. Regarding the dividends, well, it may become a qualitative type of explanation. However, this fiscal year's performance and also from next fiscal year's onwards performance outlook, we took a comprehensive look at those and decided on it. And regarding this fiscal year, the first half business performance was quite strong. And also regarding the second half, there are some uncertainties. Therefore, we do consider certain risk factors. But considering all that, we have decided on the amount of dividend. So in that sense, as you pointed out, Mr. Okazaki, The past record high of ¥24, of course, as a company, we would like to aim to do that. However, the uncertainties in the future and some outlook for our next fiscal year onwards, if it becomes brighter, we would like to decide upon the dividend once again. Okay, understood very well. That's all. Thank you very much. Thank you.
Yamauchi
Managing Executive Officer
Thank you very much, Mr. Okazaki. Let me move to the next question. From UBS Securities, Omura-san. Thank you. I'm Omura from UBS Securities. I have a question about the cash flow on page 14, investment cash flows. The plan for this year, 150 billion, and it seems that the progress is slightly higher. So in the first half, Cash flows for investing activities about the content and the full year plan. Are there any changes in the plan? Thank you for the question. Cash flows annual forecast, the revised figures are not being disclosed. But performance itself is good. Positive factors on cash flow do exist. However, on the other hand, we're seeing improvement in performance. There is improvement of equity method investment gains and also inventory valuation gains not related to cash flows. So I think that should also be taken into consideration. That is all. Thank you very much. For cash flows from investing activities, any major item in the first half and from second half onwards, compared to the initial 150 billion yen, is there anything that would go beyond that level? Maybe inflation may be related. The first half, cash flows from investing activities, partially, Not ordinary capital investment M&A but from accounting reasons like surplus funds even if that is deposited on banks for more than three months that would be deducted as investment activities cash flow and in the first half these items are included so compared to the actual situation cash flows from investing activities may look bigger But this is a one-time case. It would return towards the end of the year. And if a second half, no major changes from what we assumed in the beginning of the year. Thank you very much. Thank you.
Matsuo
General Manager, Accounting Department
Mr. Uemura, thank you very much. I'd like to take the next question from Morgan Stanley, MUFG Securities. Mr. Watabe, please go ahead. Sorry for the second round question. I wanted to ask about the dividends as well, but that was already asked. So Petro Rabic's third quarter financial results within there, there were geopolitical disruptions. Such wording was used. Even though the refinery margin was so good, the profit was not so good. Is that because of this reason or the trade of homes is closed right now? But the Red Sea side is in operation. And because of that, is there some confusion regarding the raw big supply? Is there any issues? Can you explain about that? Thank you very much for your question. Regarding petrol raw big, At the Middle East, there are various media reporting. However, from the company side, it will be the financial results announcement. So information more than that, it's difficult to share that with you in a public situation. At this point, we do not think that there is a large impact in the shipment. And for the July situation, there was a slight impact for the operation, but our understanding is that that was the reason. So there was an impact on the operation. What was the reason for that? The Middle East situation. I cannot share details with you because right now in the Middle East various things are occurring and of course we understand that there are various risks there as well. But partially there was some impact to the operation that became Thank you very much Mr. Watabe.
Yamauchi
Managing Executive Officer
We still have a few minutes before the scheduled time to close. We can receive one more question. Any other questions? If you have any questions, please let us know. Mr. Yamada from Mizuho Securities. Thank you. I'm Yamada from Mizuho Securities. So I have one question. This may be a very detailed question today. The final contract of succession of Takara was announced today and in Q3, from Q3, this business is going to be consolidated and for advanced medical solutions this business would be included. So in the first half there was a slight underachievement and of course There is a final agreement in July. So I think it is included in August. But advanced medicals now is no change. Because of this succession in the second half, do we expect a shift to surplus? And towards the next fiscal year, can we expect improvement? Or would this be included under others? Could you tell me that? Thank you for waiting. Yes, as I mentioned in the second half, that will be included in the ADM segment. For the first half and second half, in the second half, there is a concentration of profit. So this is one of the factors, but rather, Under pharma solutions, shipment timing is one factor. So it is more of a second half business. So that is the situation. I understand. So last year I think there was a loss of 1.4 billion in the first half and positive 2.4 billion in the second half. A pattern like last year and also former Takara's business will also be making contributions. Is that correct? Yes, your understanding is correct.
Matsuo
General Manager, Accounting Department
Thank you very much.
Yamauchi
Managing Executive Officer
Thank you.
Matsuo
General Manager, Accounting Department
Mr. Yamada, thank you very much. It has become close to the scheduled ending time, so we'd like to take the last question as the last question from Daiwa Securities. And Mr. Umebayashi, please go ahead. This is Umebayashi from Daiwa Securities. Regarding the methionine, I would like to ask some confirmation questions. The second half, the price is in line with what you have expected, is what you said. To begin with... This first half, it was slightly high. That is because there was a supply restrictions or constraints of your competitor and that has become resolved. So the price has gone back to the usual price. Compared to the start of the fiscal year plan, it seems that slightly the raw material prices is changing. So the way of thinking towards the margin, can it remain as the same as the start of the fiscal year? I just wanted to confirm that. Thank you very much for your question. Regarding methionine... In the first half, as you saw, the confusion of the supply and demand has started to settle down. However, the raw material prices has remained high. So for us, we would like to thoroughly discuss with our customers so that we'll be able to pass on the cost. That's how we will think about it. So I'd like you to understand in that way as well. OK, thank you. Thank you.
Yamauchi
Managing Executive Officer
Thank you very much, Mr. Umebayashi. This concludes today's conference call. Thank you very much for your participation.